RIGHTSMIL Inactive Instrument
RIGHTSMIL Stock Other OTC
Equities
US76657X1037
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | Bud Genius, Inc. cancelled the acquisition of Evergreen Licensing. | CI |
| 2015 | Bud Genius, Inc.'s Board intends to launch an Equity Buyback. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2009 | - | Sales 2010 | 0.04 0.06 | Capitalization | 11.25K 15.44K |
|---|---|---|---|---|---|
| Net income 2009 | - 0 | Net income 2010 | - 0 | EV / Sales 2009 | - |
| Net Debt 2009 | 489K 671K | Net Debt 2010 | 396K 544K | EV / Sales 2010 | 9,639,795 x |
| P/E ratio 2009 |
-23.5
x | P/E ratio 2010 |
-
| Employees | - |
| Yield 2009 * |
-
| Yield 2010 |
-
| Free-Float | 690.57% |
More Fundamentals
* Assessed data
More news
Rightsmile, Inc provides medical marijuana testing and medicine matching services. The Company works with dispensary, growers, product manufacturers and patients. It accepts selections from customersâ strain inventory and returns them the reporting package in the industry. All of its testing results are stored online. The Company provides three forms of strain identification markers, which include BudGenius StrainId Card, BudGenius StrainId Online Badge and BudGenius StrainId Certified Labels. The BudGenius StrainId Card is an identification card that ensures to patients that their test results are not modified through Photoshop trickery. The Company offers two types of reports for medical marijuana testing and strain information, which include BudGenius Scientific Analysis Online Report and BudGenius Scientific Analysis Written Report.
| 1st Jan change | Capi. | |
|---|---|---|
| +22.56% | 46.4B | |
| -1.51% | 41.75B | |
| +48.83% | 41.37B | |
| -3.42% | 29.71B | |
| +10.13% | 26.01B | |
| -20.44% | 19.52B | |
| +26.45% | 12.43B | |
| -0.14% | 12.18B | |
| -0.47% | 12.13B |
